Cargando…

Correlation between gut microbiota and glucagon-like peptide-1 in patients with gestational diabetes mellitus

BACKGROUND: Gestational diabetes mellitus (GDM) places both the mother and offspring at high risk of complications. Increasing evidence suggests that the gut microbiota plays a role in the pathogenesis of GDM. However, it is still unclear whether the gut microbiota is related to blood biochemical tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Yun-Yi, Liu, Ling-Yu, Jia, Yan, Li, Yi, Cai, Jie-Na, Shu, Yi, Tan, Jing-Yi, Chen, Pei-Yi, Li, Hong-Wei, Cai, Hui-Hua, Cai, Xiang-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606788/ https://www.ncbi.nlm.nih.gov/pubmed/36311998 http://dx.doi.org/10.4239/wjd.v13.i10.861

Ejemplares similares

Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs) – induced apoptosis
por: Zhan, Yi, et al.
Publicado: (2012)

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus
por: Patel, Vishal J, et al.
Publicado: (2018)

A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
por: Zhao, Li, et al.
Publicado: (2018)

Enhanced glucose homeostasis via Clostridium symbiosum-mediated glucagon-like peptide 1 inhibition of hepatic gluconeogenesis in mid-intestinal bypass surgery
por: Luo, Xin, et al.
Publicado: (2023)

Investigating causal associations among gut microbiota, gut microbiota-derived metabolites, and gestational diabetes mellitus: a bidirectional Mendelian randomization study
por: Wu, Xinrui, et al.
Publicado: (2023)

Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus
por: Zykov, Vladislav A, et al.
Publicado: (2018)

Faecal and mucosal microbiota in patients with functional gastrointestinal disorders: Correlation with toll-like receptor 2/toll-like receptor 4 expression
por: Dong, Li-Na, et al.
Publicado: (2017)

Regulation of glucagon‐like peptide‐1 sensitivity by gut microbiota dysbiosis
por: Yamane, Shunsuke, et al.
Publicado: (2017)

Analysis of long noncoding RNA-associated competing endogenous RNA network in glucagon-like peptide-1 receptor agonist-mediated protection in β cells
por: Cui, Li-Juan, et al.
Publicado: (2020)

Effect of Aging and Glucagon-like Peptide 2 on Intestinal Microbiota in SD Rats
por: Wu, Jiayu, et al.
Publicado: (2018)

Glucagon-like peptide-2 modulates the nitrergic neurotransmission in strips from the mouse gastric fundus
por: Garella, Rachele, et al.
Publicado: (2017)

The Herb Pair Radix Rehmanniae and Cornus Officinalis Attenuated Testicular Damage in Mice With Diabetes Mellitus Through Butyric Acid/Glucagon-Like Peptide-1/Glucagon-Like Peptide-1 Receptor Pathway Mediated by Gut Microbiota
por: Chen, Yuping, et al.
Publicado: (2022)

Gut Microbiota Modification via Glucagon-like Peptide-1 with Beneficial Neuroprotective Effects
por: Sayehmiri, Fatemeh, et al.
Publicado: (2022)

Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats
por: Ibnat, Nabilah, et al.
Publicado: (2022)

Gut mucosal microbiota profiles linked to colorectal cancer recurrence
por: Huo, Rui-Xue, et al.
Publicado: (2022)

Differences in metabolic improvement after metabolic surgery are linked to the gut microbiota in non-obese diabetic rats
por: Luo, Xin, et al.
Publicado: (2023)

Glucagon-like Peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation
por: Xie, Xiao-Yun, et al.
Publicado: (2011)

Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota
por: Chung, Ji Yeon, et al.
Publicado: (2020)

Study Insights into Gastrointestinal Cancer through the Gut Microbiota
por: Kong, Fanli, et al.
Publicado: (2019)

Glucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats
por: Cai, Xiang-Sheng, et al.
Publicado: (2017)

Glucagon‐like peptide‐1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism
por: Lin, Ke, et al.
Publicado: (2023)

Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension
por: Helmstädter, Johanna, et al.
Publicado: (2020)

Generalizability of the Results of Cardiovascular Outcome Trials of Glucagon-Like Peptide 1 Receptor Agonists in Chinese Patients with Type 2 Diabetes Mellitus
por: Cai, Xiaoling, et al.
Publicado: (2021)

Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression
por: YI, BO, et al.
Publicado: (2014)

Glucagon Like Peptide-1 Promotes Adipocyte Differentiation via the Wnt4 Mediated Sequestering of Beta-Catenin
por: Liu, Rui, et al.
Publicado: (2016)

Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats
por: Xu, Chun-Lan, et al.
Publicado: (2018)

Simo decoction curing spleen deficiency constipation was associated with brain-bacteria-gut axis by intestinal mucosal microbiota
por: Yi, Xin, et al.
Publicado: (2023)

Comparative analysis of the gut microbiota of wild adult rats from nine district areas in Hainan, China
por: Niu, Li-Na, et al.
Publicado: (2023)

The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction
por: Li, Zi‐Han, et al.
Publicado: (2023)

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor
por: Sun, Wen, et al.
Publicado: (2020)

Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation
por: Wen, Xin, et al.
Publicado: (2021)

Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells
por: Lu, Cai-Jie, et al.
Publicado: (2017)

Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice
por: Wang, Xin, et al.
Publicado: (2017)

Correlations between gut microbiota community structures of Tibetans and geography
por: Lan, Daoliang, et al.
Publicado: (2017)

Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study
por: Liu, Xia, et al.
Publicado: (2021)

The Utilization of Glucagon-like Peptide 1 Agonists and Risk of Following External Eye Diseases in Type 2 Diabetes Mellitus Individuals: A Population-Based Study
por: Fan, Ying-Chi, et al.
Publicado: (2023)

Alterations of Gut Microbiota and Blood Lipidome in Gestational Diabetes Mellitus With Hyperlipidemia
por: Liu, He, et al.
Publicado: (2019)

p66Shc-mediated oxidative stress is involved in gestational diabetes mellitus
por: Huang, Ting-Ting, et al.
Publicado: (2021)

Diet-Gut Microbiota Interactions and Gestational Diabetes Mellitus (GDM)
por: Ponzo, Valentina, et al.
Publicado: (2019)

Diversified gut microbiota in newborns of mothers with gestational diabetes mellitus
por: Su, Minglian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lrs19a828dilitgrlmj59spag0